Long viewed as one of the biggest hype-to-disappointment stories in pharmaceutical history, the PCSK...
As FDA makes Lipfendra poster child of CNPV pilot, Merck charts long-term path for first PCSK9 pill
Long viewed as one of the biggest hype-to-disappointment stories in pharmaceutical history, the PCSK9 cholesterol drug class has struggled to live up to its...
Author: Fierce Pharma
Read Original Article